The Experts below are selected from a list of 3576 Experts worldwide ranked by ideXlab platform
Hongzhi Tang - One of the best experts on this subject based on the ideXlab platform.
-
Genome sequence of the thermophile Bacillus Coagulans Hammer, the type strain of the species.
Journal of bacteriology, 2012Co-Authors: Fei Tao, Hongzhi TangAbstract:Here we announce a 3.0-Mb assembly of the Bacillus Coagulans Hammer strain, which is the type strain of the species within the genus Bacillus. Genomic analyses based on the sequence may provide insights into the phylogeny of the species and help to elucidate characteristics of the poorly studied strains of Bacillus Coagulans.
-
genome sequence of the thermophilic strain Bacillus Coagulans xzl4 an efficient pentose utilizing producer of chemicals
Journal of Bacteriology, 2011Co-Authors: Bo Zhao, Fei Tao, Cui Tai, Hongzhi TangAbstract:ABSTRACT Bacillus Coagulans XZL4 is an efficient pentose-utilizing producer of important platform compounds, such as l-lactic acid, 2,3-butanediol, and acetoin. Here we present a 2.8-Mb assembly of its genome. Simple and efficient carbohydrate metabolism systems, especially the transketolase/transaldolase pathway, make it possible to convert pentose sugars to products at high levels.
Ratna Sudha Madempudi - One of the best experts on this subject based on the ideXlab platform.
-
Bacillus Coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
Probiotics and Antimicrobial Proteins, 2019Co-Authors: Ratna Sudha Madempudi, Jayanthi Neelamraju, Jayesh J. Ahire, Sandeep K. Gupta, Vineet K. ShuklaAbstract:Functional constipation has a high prevalence in both adults and children affecting quality of life. Evidence suggests that probiotics can reduce the symptoms of constipation. As the effects of probiotics are strain specific, the efficacy of Bacillus Coagulans Unique IS2 in the treatment of functional constipation in adults was evaluated. Subjects ( n = 100) diagnosed with functional constipation were supplemented with either B. Coagulans Unique IS2 (2 billion CFU) or placebo capsules once daily for 4 weeks. Subjects were evaluated for treatment success (defined as three or more spontaneous stools per week), stool consistency, difficulty of defecation, defecation and abdominal pain. By the end of the fourth week, there was a statistically significant ( p
-
Bacillus Coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
Probiotics and Antimicrobial Proteins, 2019Co-Authors: Ratna Sudha Madempudi, Jayanthi Neelamraju, Jayesh J. Ahire, Sandeep K. Gupta, Vineet K. ShuklaAbstract:Functional constipation has a high prevalence in both adults and children affecting quality of life. Evidence suggests that probiotics can reduce the symptoms of constipation. As the effects of probiotics are strain specific, the efficacy of Bacillus Coagulans Unique IS2 in the treatment of functional constipation in adults was evaluated. Subjects ( n = 100) diagnosed with functional constipation were supplemented with either B. Coagulans Unique IS2 (2 billion CFU) or placebo capsules once daily for 4 weeks. Subjects were evaluated for treatment success (defined as three or more spontaneous stools per week), stool consistency, difficulty of defecation, defecation and abdominal pain. By the end of the fourth week, there was a statistically significant ( p
-
Antiproliferative Effects of Bacillus Coagulans Unique IS2 in Colon Cancer Cells.
Nutrition and cancer, 2017Co-Authors: Ratna Sudha Madempudi, Arunasree M. KalleAbstract:In the present study, the in vitro anticancer (antiproliferative) effects of Bacillus Coagulans Unique IS2 were evaluated on human colon cancer (COLO 205), cervical cancer (HeLa), and chronic myelo...
-
Draft Genome Sequence of the Spore-Forming Probiotic Strain Bacillus Coagulans Unique IS-2.
Genome announcements, 2016Co-Authors: Aditya Upadrasta, Swetha Pitta, Ratna Sudha MadempudiAbstract:ABSTRACT Bacillus Coagulans Unique IS-2 is a potential spore-forming probiotic that is commercially available on the market. The draft genome sequence presented here provides deep insight into the beneficial features of this strain for its safe use as a probiotic for various human and animal health applications.
Fei Tao - One of the best experts on this subject based on the ideXlab platform.
-
Genome sequence of the thermophile Bacillus Coagulans Hammer, the type strain of the species.
Journal of bacteriology, 2012Co-Authors: Fei Tao, Hongzhi TangAbstract:Here we announce a 3.0-Mb assembly of the Bacillus Coagulans Hammer strain, which is the type strain of the species within the genus Bacillus. Genomic analyses based on the sequence may provide insights into the phylogeny of the species and help to elucidate characteristics of the poorly studied strains of Bacillus Coagulans.
-
genome sequence of the thermophilic strain Bacillus Coagulans xzl4 an efficient pentose utilizing producer of chemicals
Journal of Bacteriology, 2011Co-Authors: Bo Zhao, Fei Tao, Cui Tai, Hongzhi TangAbstract:ABSTRACT Bacillus Coagulans XZL4 is an efficient pentose-utilizing producer of important platform compounds, such as l-lactic acid, 2,3-butanediol, and acetoin. Here we present a 2.8-Mb assembly of its genome. Simple and efficient carbohydrate metabolism systems, especially the transketolase/transaldolase pathway, make it possible to convert pentose sugars to products at high levels.
Ira Schildkraut - One of the best experts on this subject based on the ideXlab platform.
-
A unique restriction endonuclease, Bcgl, from Bacillus Coagulans
Nucleic acids research, 1993Co-Authors: Huimin Kong, Richard D. Morgan, Robert Maunus, Ira SchildkrautAbstract:We have purified and characterized a new restriction endonuclease, BcgI, which has properties unlike those of the three recognized classes of restriction enzymes. BcgI was isolated from Bacillus Coagulans, and it recognizes the sequence CGAN6TGC. BcgI cleaves double stranded DNA on both strands upstream and downstream of the recognition sequence, so that the recognition sequence is released as a 34-base pair fragment with 2-base 3'-extensions. Mg++ and S-adenosylmethionine are required for cleavage. Sinefungin, a structural analogue of AdoMet which generally inhibits methylase activity, can replace AdoMet in the cleavage reaction. The apparent binding constant (Kappd) for AdoMet is about 100 nM, while the KappD for sinefungin is about 500 nM.
Vineet K. Shukla - One of the best experts on this subject based on the ideXlab platform.
-
Bacillus Coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
Probiotics and Antimicrobial Proteins, 2019Co-Authors: Ratna Sudha Madempudi, Jayanthi Neelamraju, Jayesh J. Ahire, Sandeep K. Gupta, Vineet K. ShuklaAbstract:Functional constipation has a high prevalence in both adults and children affecting quality of life. Evidence suggests that probiotics can reduce the symptoms of constipation. As the effects of probiotics are strain specific, the efficacy of Bacillus Coagulans Unique IS2 in the treatment of functional constipation in adults was evaluated. Subjects ( n = 100) diagnosed with functional constipation were supplemented with either B. Coagulans Unique IS2 (2 billion CFU) or placebo capsules once daily for 4 weeks. Subjects were evaluated for treatment success (defined as three or more spontaneous stools per week), stool consistency, difficulty of defecation, defecation and abdominal pain. By the end of the fourth week, there was a statistically significant ( p
-
Bacillus Coagulans Unique IS2 in Constipation: A Double-Blind, Placebo-Controlled Study
Probiotics and Antimicrobial Proteins, 2019Co-Authors: Ratna Sudha Madempudi, Jayanthi Neelamraju, Jayesh J. Ahire, Sandeep K. Gupta, Vineet K. ShuklaAbstract:Functional constipation has a high prevalence in both adults and children affecting quality of life. Evidence suggests that probiotics can reduce the symptoms of constipation. As the effects of probiotics are strain specific, the efficacy of Bacillus Coagulans Unique IS2 in the treatment of functional constipation in adults was evaluated. Subjects ( n = 100) diagnosed with functional constipation were supplemented with either B. Coagulans Unique IS2 (2 billion CFU) or placebo capsules once daily for 4 weeks. Subjects were evaluated for treatment success (defined as three or more spontaneous stools per week), stool consistency, difficulty of defecation, defecation and abdominal pain. By the end of the fourth week, there was a statistically significant ( p